NewsTargeted delivery of therapeutic RNAs directly to cancer
cells

29th June 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/06/targeted-delivery-of-therapeutic-rnas-directly-to-cancercells_60dc400022030.jpeg

Tel Aviv University’s groundbreaking technology may
revolutionize the treatment of cancer and a wide range of diseases
and medical conditions. In the framework of this study, the
researchers were able to create a new method of transporting
RNA-based drugs to a subpopulation of immune cells involved in the
inflammation process, and target the disease-inflamed cell without
causing damage to other cells.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick